CA53846-1 - 0x000000000000737F

Males & Females of Non-Childbearing Potential

Eggwhite

* Stipend may pay up to reflected amount.
Start Date: 
November 6, 2026 - 1:45pm
End Date: 
January 5, 2027 - 11:15am

Study Details

Study Number: CA53846
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $15,750.00

Study Criteria

Age: 19 - 55
BMI: 18 - 29.9
Weight Restriction: minimum weight 111 lbs

Study Information

Indication: This marketed medication is approved to treat thyroid cancer.
Route of Administration: Oral
Blood Draws: 46

Study Schedule

Schedule Type: Long Term
Study Length: Two - 11 Nights Stays, 7 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date
Monday 10/26/2026
Tuesday 10/27/2026
Wednesday 10/28/2026
Friday 10/30/2026
Wednesday 11/4/2026
Thursday 11/5/2026

Doctor Exam Dates:

Event Day Event Date
Monday 10/26/2026
Tuesday 10/27/2026
Wednesday 10/28/2026
Friday 10/30/2026
Wednesday 11/4/2026
Thursday 11/5/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Friday 11/6/2026 1:45:00 PM Tuesday 11/17/2026 8:45:00 AM 1 Lincoln
Return Friday 11/20/2026 7:15:00 AM Friday 11/20/2026 8:30:00 AM 1 Lincoln
Return Tuesday 11/24/2026 7:15:00 AM Tuesday 11/24/2026 8:30:00 AM 1 Lincoln
Return Saturday 11/28/2026 7:15:00 AM Saturday 11/28/2026 8:45:00 AM 1 Lincoln
Check-In Saturday 12/5/2026 1:45:00 PM Wednesday 12/16/2026 8:45:00 AM 2 Lincoln
Return Saturday 12/19/2026 7:15:00 AM Saturday 12/19/2026 8:30:00 AM 2 Lincoln
Return Wednesday 12/23/2026 7:15:00 AM Wednesday 12/23/2026 8:30:00 AM 2 Lincoln
Return Saturday 12/26/2026 7:15:00 AM Saturday 12/26/2026 8:45:00 AM 2 Lincoln
Return Sunday 12/27/2026 7:15:00 AM Sunday 12/27/2026 8:30:00 AM 2 Lincoln
Phone participant Tuesday 1/5/2027 11:15:00 AM 2 Lincoln